Profile
Sector:
EnergyIndustry:
Oil & Gas MidstreamCountry:
United StatesIPO:
29 September 2005Website:
http://www.globalp.comNext earnings report:
08 November 2024Last dividends:
08 August 2024Next dividends:
N/APrice
after hours | Wed, 11 Sep 2024 21:57:29 GMTAnalysts recommendations
Institutional Ownership
GLP Latest News
'Mad Money' host Jim Cramer looks at how Mondelez is dealing with GLP-1 drugs.
Amid an ongoing debate over what role, if any, GLP-1 medications should play in treating children who are still in elementary school, researchers have concluded that a Novo Nordisk obesity drug may be safe and effective for kids as young as 6 years of age.
Company announcement – No. 44 / 2024 Zealand Pharma announces positive topline results from 13-week Phase 1b multiple ascending dose clinical trial with GLP-1/GLP-2 receptor dual agonist dapiglutide Placebo-adjusted reductions in body weight of up to a mean of 8.3% with dapiglutide after 13 weekly doses Dapiglutide treatment with doses up to 13 mg was assessed to be safe and well-tolerated with gastrointestinal adverse events consistent with the profile reported with other incretin-based therapies Higher doses up to 26 mg over a 28-week treatment period are being evaluated in the ongoing Part 2 of the trial with topline results expected in the first half of 2025 Copenhagen, Denmark, 9 September 2024 – Zealand Pharma A/S ("Zealand") (Nasdaq: ZEAL), (CVR-no.
Meet with Modular Medical CEO, Jeb Besser There are more than 3 million individuals who use daily insulin to help with the care of Diabetes in the US.100% of patient population require daily insulin injection. Only 20% currently use an insulin pump.
TAMPA, Fla. , Sept. 4, 2024 /PRNewswire/ -- Integrated Ventures Inc. (OTCQB: INTV), a holdings company, focused on e-commerce technology, digital assets and consumer-focused investments, is excited to announce (1) formation and launch of our second, fully funded, 100% owned subsidiary - MedWellDirect, LLC, Direct-To-Consumer (D2C) telemedicine solutions provider, mainly for weight loss and GLP-1 products and (2) acquisition of 51% stake in GetTrim.Com (TM), owned by Healthy Lifestyle USA – an innovative telemedicine weight loss services provider.
The advent of GLP-1 weight-loss treatments has inadvertently underscored the importance of protein in mitigating muscle loss. While taking GLP-1 meds may be out of reach of many consumers due to exorbitant out-of-pocket costs and limited health insurance coverage, the popularity of high protein diets like keto or carnivore continues to gain popularity as a natural method to lose weight.
The surge in interest investors have displayed for companies delivering weight loss drugs has been impressive.
TAMPA, Fla. , Aug. 28, 2024 /PRNewswire/ -- Integrated Ventures, Inc. (OTCQB: INTV), a diversified portfolio holdings company, is excited to announce its strategic entry into the rapidly expanding health and wellness sector.
In conjunction with this new offering, 23andMe, Lemonaid Health's parent company, recently launched study focused on the role genetics may play in effectiveness and side effects of GLP-1s In conjunction with this new offering, 23andMe, Lemonaid Health's parent company, recently launched study focused on the role genetics may play in effectiveness and side effects of GLP-1s
Pharmaceutical companies have significantly grown over the last year as demand for GLP-1 weight-loss drugs continues to skyrocket. Roundhill Investments CEO Dave Mazza joins Market Domination for the latest installment of Good Buy or Goodbye to analyze his top pick in the GLP-1 market.
What type of business is Global Partners LP?
Global Partners LP engages in the purchasing, selling, gathering, blending, storing, and logistics of transporting gasoline and gasoline blendstocks, distillates, residual oil, renewable fuels, crude oil, and propane to wholesalers, retailers, and commercial customers. The company operates through three segments: Wholesale, Gasoline Distribution and Station Operations, and Commercial. The Wholesale segment sells home heating oil, branded and unbranded gasoline and gasoline blendstocks, diesel, kerosene, and residual oil to home heating oil and propane retailers and wholesale distributors. This segment also transports the products by railcars, barges, trucks and/or pipelines. Its Gasoline Distribution and Station Operations segment sells branded and unbranded gasoline to gasoline station operators and sub-jobbers; operates gasoline stations and convenience stores; and provides car wash, lottery, and ATM services, as well as leases gasoline stations. The Commercial segment sells and delivers unbranded gasoline, home heating oil, diesel, kerosene, residual oil, and bunker fuel to customers in the public sector, as well as to commercial and industrial end-users; and sells custom blended fuels. The company is also involved in the transportation of petroleum products and renewable fuels through rail from the mid-continent region of the United States and Canada. Global Partners LP was founded in 2005 and is based in Waltham, Massachusetts.
What sector is Global Partners LP in?
Global Partners LP is in the Energy sector
What industry is Global Partners LP in?
Global Partners LP is in the Oil & Gas Midstream industry
What country is Global Partners LP from?
Global Partners LP is headquartered in United States
When did Global Partners LP go public?
Global Partners LP initial public offering (IPO) was on 29 September 2005
What is Global Partners LP website?
https://www.globalp.com
Is Global Partners LP in the S&P 500?
No, Global Partners LP is not included in the S&P 500 index
Is Global Partners LP in the NASDAQ 100?
No, Global Partners LP is not included in the NASDAQ 100 index
Is Global Partners LP in the Dow Jones?
No, Global Partners LP is not included in the Dow Jones index
When was Global Partners LP the previous earnings report?
No data
When does Global Partners LP earnings report?
The next expected earnings date for Global Partners LP is 08 November 2024